[T1-T2 prostate cancer: treatment by radiation therapy].
Prostate cancers are a complex entity. Many factors must be taken in account in the therapeutic discussion. Identification of group of risk authorizes to better adapt the treatment. External radiation therapy is efficient and the analysis of the literature shows that this technique is effective. With new modalities, in particular with conformal irradiation, it is possible to optimize the dose and to limit the risk of complications. Brachytherapy is an other possibility with very good result for patients of the low risk group. But these two modalities were never directly compared. This opportunity should be discuss in the future.
Lagrange
Jean-Léon
JL
APHP, hôpital Henri-Mondor, CHU Créteil, Université Paris XII, EMI 0337 54 avenue du Maréchal-de-Lattre-de -Tassigny, 94000 Créteil. jean-leon.lagrange@hmn.aphp.fr
Guerif
Stéphane
S
D001918:Brachytherapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000532:radiotherapy*; D020266:Radiotherapy, Conformal; D018570:Risk Assessment; D016896:Treatment Outcome
D017430:Prostate-Specific Antigen